Human papillomavirus infection in Egyptian esophageal carcinoma: Correlation with p53, p21waf, mdm2, C-erbB2 and impact on survival
- 1 February 2005
- journal article
- Published by Wiley in Pathology International
- Vol. 55 (2) , 53-62
- https://doi.org/10.1111/j.1440-1827.2005.01804.x
Abstract
The etiological role of human papillomavirus (HPV) in esophageal carcinoma (EC) in relation to p53, mdm2, p21(waf), c-erbB2 and the overall survival (OS) rate was investigated. Tumor and normal tissues from 50 EC were evaluated by polymerase chain reaction and InnoLiPA for HPV. Single strand conformation polymorphism/sequencing were used to detect p53 gene mutations. Immunohistochemistry was performed to determine p53, mdm2, p21(waf)and c-erbB2 expression. Human papillomavirus was detected in 54% of tumors and in 24% of normal tissues. p53, mdm2 and c-erbB2 overexpression was detected in 68%, 70% and 60% of tumors and in 14%, 16% and 10% of normal samples, whereas loss of p21(waf) was evident in 64% of tumors. p53 mutations were detected in 20% of cases. Exon 8 and 5 showed the highest mutation rate (40% each), followed by exons 6 and 7 (10% each). There was a significant correlation between HPV and p53, mdm2, c-erbB2 overexpression. The OS was significantly associated with overexpression of p53 and loss of p21(waf). Human papillomavirus infection is frequent in Egyptian EC. Both p53-dependent and p53-independent pathways seem to be involved in HPV-associated EC. mdm2 and c-erbB2 are possible targets for HPV in the p53-independent pathway. However, only advanced stage and aberrant expression of p53 and p21(waf) are independent prognostic markers.Keywords
This publication has 27 references indexed in Scilit:
- Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinomaCarcinogenesis: Integrative Cancer Research, 2003
- c-erbB-2 (HER-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapyInternational Journal of Cancer, 1999
- Prognostic Value of Laurén Classification and c-erbB-2 Oncogene Overexpression in Adenocarcinoma of the Esophagus and Gastroesophageal JunctionAnnals of Surgical Oncology, 1999
- C-erbB-2 protein expression in oesophageal squamous epithelium from oesophageal squamous cell carcinomas, with special reference to histological grade of carcinoma and pre-invasive lesionsEuropean Journal of Surgical Oncology, 1998
- Absence of human papillomavirus DNA from esophageal carcinoma as determined by multiple broad spectrum polymerase chain reactionsJournal of Medical Virology, 1995
- Human papillomavirus DNA in oesophageal carcinomas in South AfricaThe Journal of Pathology, 1995
- Estimates of the worldwide incidence of eighteen major cancers in 1985International Journal of Cancer, 1993
- Human papillomavirus (HPV) DNA in esophageal precancer lesions and squamous cell carcinomas from ChinaInternational Journal of Cancer, 1990
- Detection of Human Papillomavirus DNA in Cytologic Specimens Derived from Esophageal Precancer Lesions and CancerScandinavian Journal of Gastroenterology, 1990
- Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell AnemiaScience, 1985